- Report
- August 2022
- 245 Pages
Global
From €2321EUR$2,625USD£2,004GBP
€4643EUR$5,250USD£4,009GBP
- Report
- June 2025
- 200 Pages
Australia
From €2202EUR$2,490USD£1,901GBP
- Report
- July 2024
- 80 Pages
Japan
From €3095EUR$3,500USD£2,672GBP
- Report
- July 2024
- 185 Pages
Global
From €3980EUR$4,500USD£3,436GBP
- Report
- May 2024
- 185 Pages
Global
From €3980EUR$4,500USD£3,436GBP
- Report
- February 2024
- 179 Pages
Global
From €3980EUR$4,500USD£3,436GBP
- Report
- February 2024
- 116 Pages
Global
From €4201EUR$4,750USD£3,627GBP
- Report
- August 2022
- 110 Pages
Global
From €4201EUR$4,750USD£3,627GBP
- Report
- August 2022
- 116 Pages
Global
From €4201EUR$4,750USD£3,627GBP
- Report
- January 2024
- 146 Pages
Global
From €3007EUR$3,400USD£2,596GBP
€3759EUR$4,250USD£3,245GBP
- Report
- December 2023
- 170 Pages
Global
From €3183EUR$3,599USD£2,748GBP
- Report
- July 2023
- 220 Pages
Global
€4064EUR$4,595USD£3,508GBP
- Report
- October 2022
- 227 Pages
Global
From €3184EUR$3,600USD£2,749GBP
- Report
- October 2022
- 250 Pages
Global
From €3184EUR$3,600USD£2,749GBP
-
Journal - August 2025
Global
From €376EUR$425USD£325GBP
- Report
- October 2024
- 96 Pages
Global
From €3500EUR$4,240USD£3,128GBP

The Physiological Science market within the context of Biotechnology is focused on the study of the human body and its functions. It involves the use of advanced technologies to understand the biological processes that occur in the body, such as metabolism, cell growth, and development. This market also includes research into the effects of drugs, nutrition, and environmental factors on the body. It is a rapidly growing field, with new discoveries being made every day.
The Physiological Science market is a major component of the biotechnology industry, as it provides the foundation for the development of new treatments and therapies. It is also used to develop diagnostic tools and medical devices. Companies in this market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more